Sideline Gold on Fe...
Services: Retail
Pharmerica Corporation (PMC: NYSE)
$16.20 0.37 | 2.34%
06/18/13 - 04:02 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:16.95
Price Earnings Comparisons:
| PMC | Sector Avg. | S&P 500 |
|---|---|---|
| 16.95 | 16.80 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 7.39 | 55.50 | 4.97 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | -11.90 | 0.00 | 0.00 |
| Net Income | -0.46 | -0.18 | |
| EPS | -2.50 | -0.44 | -0.17 |
Earnings for PMC:
| EBITDA | 105.10M |
| REVENUE | 1.83B |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $0.31 | $0.30 | $1.34 | $1.48 |
| Number of Analysts | 3 | 3 | 3 | 3 |
| High Estimate | $0.32 | $0.34 | $1.40 | $1.55 |
| Low Estimate | $0.30 | $0.26 | $1.28 | $1.39 |
| Prior Year | $0.32 | $0.33 | $1.27 | $1.34 |
| Growth Rate (Year over Year) | -3.12% | -10.10% | 5.77% | 10.17% |
Portfolios with PMC
- Portfolio NameUser Type
- UserSmall Cap Value
- UserDavese Portfolio 1
- UserPART 1 JPMorgan 28th Annual...
- ContributorBarron's Insider Purchases ...
- UserPART 4 JPMorgan 27th Annual...
- UserCramer's Take on Top 10 Mos...
- UserBarron's Interview John Kee...
- UserCramer's Take on Top 10 Mos...
- UserCramer's Take On Ladies Nig...
- UserPART 7 JPMorgan 26th Annual...
Latest PMC Headlines from TheStreet
- 5 Stocks Soaring on Unusual Volume 05.24.13 | 02:05 pm
- July Options Now Available For PharMerica (PMC) 05.20.13 | 05:05 pm
- Pharmerica Corporation Stock Upgraded (PMC) 05.07.13 | 05:05 am
- TheStreet Ratings Top 10 Rating Changes 04.23.13 | 09:04 am
- Oversold Conditions For PharMerica (PMC) 04.22.13 | 12:04 pm
- Pharmerica Corporation Stock Downgraded (PMC) 04.22.13 | 05:04 am
- Why I'm Holding On To Apple 04.10.13 | 07:04 am
- Pharmerica Corporation Stock Upgraded (PMC) 11.14.12 | 04:11 am
- Pharmerica Stock Hits New 52-Week Low (PMC) 06.12.12 | 10:06 am
- Pharmerica Stock Hits New 52-Week Low (PMC) 05.31.12 | 11:05 am
Press Releases for PMC
- PharMerica To Present At The Barclays Global Healthcare Conference - Business Wire 03.07.13 | 10:03 am
- PharMerica To Present At The Cowen And Company 33rd Annual Health Care Conference - Business Wire 02.27.13 | 10:02 am
- PharMerica To Present At The RBC Capital Markets 2013 Healthcare Conference - Business Wire 02.20.13 | 10:02 am
- PharMerica To Present At The Citi 2013 Global Healthcare Conference - Business Wire 02.19.13 | 10:02 am
- PharMerica Reports Results For The Fourth Quarter Of 2012 And Year Ended December 31, 2012 - Business Wire 02.07.13 | 04:02 pm
- PharMerica To Present At The Leerink Swann Global Healthcare 2013 Conference - Business Wire 02.06.13 | 11:02 am
- PharMerica Corporation To Broadcast Fourth Quarter And Year-End 2012 Results Conference Call Live On The Internet - Business Wire 01.16.13 | 07:01 am
- PharMerica To Present At The Noble Financial Capital Markets Ninth Annual Equity Conference - Business Wire 01.16.13 | 07:01 am
- PharMerica Corporation Names Patrick G. LePore To Its Board Of Directors - Business Wire 01.14.13 | 07:01 am
- PharMerica Corporation Acquires Amerita, Inc. - Business Wire 12.13.12 | 04:12 pm
Partner Headlines for PMC
- OCR Seals Distribution Rights - Analyst Blog - NASDAQ 09.18.12 | 10:09 pm
- OCR Hikes Dividend; Ups Buyback - Analyst Blog - NASDAQ 09.17.12 | 04:09 pm
- Weekly CFO Buys Highlight: PMC, ZBB - GuruFocus 06.25.12 | 03:06 pm
- Weekly CEO Buys Highlight: UTHR, PMC, ABR, AIR, SCHS - GuruFocus 06.23.12 | 07:06 pm
- Weekly CFO Buys Highlight: ZBB, INO, LPR, PMC, FGP, PRMW - GuruFocus 06.17.12 | 02:06 pm
- Weekly CEO Buys Highlight: UTHR, TAT, PMC, BRCD, ENDP - GuruFocus 06.16.12 | 09:06 pm
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 04.12.12 | 09:04 am
- Zacks Releases Four Powerful ''Buy'' Stocks: Procera Networks, T. Rowe Price Group, Pharmerica and Jarden - Press Releases - Zacks 03.21.12 | 09:03 am
- Pharmerica - Momentum - Zacks 03.21.12 | 01:03 am
- PharMerica Comments on Omnicare's Decision to Allow Its Unsolicited Tender Offer to Expire - Benzinga 02.21.12 | 09:02 am
